Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001334374 | SCV001527202 | uncertain significance | Plasminogen deficiency, type I | 2018-06-06 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Fulgent Genetics, |
RCV002493731 | SCV002797575 | uncertain significance | Plasminogen deficiency, type I; Angioedema, hereditary, 4 | 2021-08-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003669234 | SCV004391089 | uncertain significance | not provided | 2023-12-18 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with threonine, which is neutral and polar, at codon 89 of the PLG protein (p.Arg89Thr). This variant is present in population databases (rs143079629, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with PLG-related conditions. ClinVar contains an entry for this variant (Variation ID: 1032300). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PLG protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |